Brief: Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System To Us FDA For 510(K) Clearance
16/09/2025 14:02
Sept 16 (Reuters) - Conavi Medical Corp CNVI.V: CONAVI MEDICAL SUBMITS NEXT GENERATION NOVASIGHT HYBRID INTRAVASCULAR IMAGING SYSTEM TO US FDA FOR 510(K) CLEARANCE CONAVI MEDICAL CORP - FDA 510(K) CLEARANCE EXPECTED H1 2026, US LAUNCH PLANNED Source text: ID:nGNX5ZCRMz Further company coverage: CNVI.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Conavi Medical
See all newsBrief: Conavi Medical Announces Pricing Of Public Offering Of Common Shares
Brief: Conavi Medical Announces Agreement With The Province Of Ontario As Part Of The Life Sciences Scale-Up Fund
Brief: Conavi Medical Submits Next Generation Novasight Hybrid Intravascular Imaging System To Us FDA For 510(K) Clearance
Brief: Conavi Medical Corp. Announces Closing Of $20M Public Offering
Brief: Titan Medical Says To Delist From Tsx & Apply To Re-List On TSX Venture Exchange